CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | RINGO WILLIAM R Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-20 | Mahony Susan Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-20 | Johnson-Pratt Lisa Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-05-20 | HOLUBIAK MYRON Z Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-20 | DiMarchi Richard D Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-20 | Consylman Gina Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-20 | ALTIG ANTHONY E Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award | +11,250 | 56,250 | ||
| 2021-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2021-03-29 | Stamm Luisa M Chief Medical Officer | Grant or award | +11,250 | 18,853 | ||
| 2021-03-29 | Stamm Luisa M Chief Medical Officer | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2021-03-29 | Russo Thomas Joseph CFO | Grant or award | +11,250 | 54,633 | ||
| 2021-03-29 | Russo Thomas Joseph CFO | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2021-03-29 | Okazaki Jason A Chief Legal & Business Officer | Grant or award | +13,750 | 67,250 | ||
| 2021-03-29 | Okazaki Jason A Chief Legal & Business Officer | Grant or award · Stock Option (right to buy) | +82,500 | 82,500 | ||
| 2021-03-29 | McHutchison John G CEO and President | Grant or award · Stock Option (right to buy) | +305,000 | 305,000 | ||
| 2020-12-14 | Papkoff Jacqueline Sybil SVP-CSO Microbiome | Sale | −1,297 | $6.15 | $8K | 37,364 |
| 2020-11-09 | Stamm Luisa M Chief Medical Officer | Sale | −4,397 | $5.10 | $22K | 7,603 |
| 2020-10-19 | Consylman Gina Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-08-07 | McHutchison John G CEO and President | Sale | −11,395 | $21.76 | $248K | 138,605 |
Page 10 of 15 · 297 trades